QT Imaging
QT Imaging (NASDAQ: QTI) develops and sells the FDA-cleared QTI Breast Acoustic CT Scanner, a radiation-free 3D transmission ultrasound system for breast imaging, serving breast imaging centers, oncology practices, and IDNs in the U.S., Saudi Arabia, UAE, and Israel.
- Company typePublic
- Founded2011
- HeadquartersNovato, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What QT Imaging does
QT Imaging Holdings, Inc. (NASDAQ: QTI) is a Novato, California-based medical device company that developed and commercializes the FDA 510(k)-cleared QTI Breast Acoustic CT Scanner, the first true 3D transmission ultrasound breast imaging system. The scanner uses low-frequency sound waves (300 kHz to 2.0 MHz) with a 2048-element PMN-PT receiver array and proprietary nonlinear inverse scattering reconstruction algorithms to produce quantitative 3D volumetric images of the breast without ionizing radiation, compression, or contrast agents. Its core differentiator is a set of Speed of Sound, attenuation, and reflection biomarkers demonstrating less than 1% measurement variability versus 11-22% for breast MRI, supporting screening of dense breast tissue, supplemental workup after inconclusive mammograms, and treatment monitoring for breast cancer patients undergoing neoadjuvant chemotherapy.
The business generates revenue primarily through hardware sales of the Breast Acoustic CT Scanner (manufactured at the Novato facility and via Canon Medical Systems in Japan), recurring single-use consumables per scan, and a growing cloud-based SaaS subscription tier (QTI Cloud Platform / InteleShare) that delivers biomarker software, AI-enabled analytics, and integration with the QT Imaging-Olea multimodality viewer. U.S. commercial operations are transitioning from a distributor-led model with NXC Imaging (a Canon Medical USA subsidiary) to a hybrid direct/distributor model with newly hired regional sales VPs, while international markets are served through exclusive distribution agreements with Gulf Medical Co. (Saudi Arabia) and Al Naghi Medical Co. (UAE). The platform achieved the first CPT code (Category III X579T) for the procedure, effective January 1, 2027, and secured regulatory clearances in the U.S., Saudi Arabia, UAE, and Israel.
QT Imaging became publicly traded in March 2024 via a business combination with GigCapital5 (a SPAC), was relisted on the Nasdaq Capital Market in January 2026 following a 3:1 reverse stock split, and has raised approximately $43 million of capital across 2025-2026 (including an $18M PIPE anchored by Sio Capital Management and a $10M underwritten public offering in May 2026) to scale production toward 80 scanner shipments in 2026 versus 12 in 2024. The company reports 11-50 employees, full-year 2025 revenue of $18.9 million, Q1 2026 revenue of $6.5 million, and 2026 revenue guidance of approximately $39 million, with EBITDA losses of -$18.3 million in 2025 reflecting growth-stage investment in commercial scale-up.
QT Imaging firmographics
Firmographics- Name
- QT Imaging
- Legal name
- QT Imaging Holdings, Inc.
- Website
- https://qtimaging.com
- Company type
- Public
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- QT Imaging (NASDAQ: QTI) develops and sells the FDA-cleared QTI Breast Acoustic CT Scanner, a radiation-free 3D transmission ultrasound system for breast imaging, serving breast imaging centers, oncology practices, and IDNs in the U.S., Saudi Arabia, UAE, and Israel.
- Ownership category
- akta.pro rank
QT Imaging industry classification
Industry- Product category
- Medical Imaging Equipment
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Mammography & Breast Imaging Systems (HLAHABAF)
- akta.pro secondary industry
- Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic) (HLACALAD)
Keywords
Where QT Imaging is headquartered
LocationHeadquarters
- HQ city
- Novato
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
QT Imaging business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Hardware Sales - Breast Acoustic CT Scanner: Sale of QTI Breast Acoustic CT Scanners to healthcare facilities. Scanners are manufactured by QTI in Novato, CA and Canon Medical in Japan. Distribution through direct sales team and channel partners including NXC Imaging (US), Gulf Medical Co. (Saudi Arabia), and Al Naghi Medical Co. (UAE).
- Cloud SaaS Platform Subscriptions: AI/Cloud SaaS platform with subscription model including per-scan, per-facility, and per-feature pricing tiers. Delivers biomarker software applications and future AI-enabled analytical capabilities through cloud-based InteleShare platform.
- Consumables - Breast Retention Devices: Single-use consumable accessories required for each scan procedure.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Per-scan pricing for QTscan procedure |
| Subscription | Annual | Cloud SaaS Platform Subscriptions |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels6 records
QT Imaging product offering
Product offeringCore offering
QT Imaging develops and sells the FDA 510(k)-cleared QTI Breast Acoustic CT Scanner, a 3D transmission ultrasound system that produces radiation-free, compression-free, contrast-free volumetric breast images and quantitative biomarkers (speed of sound, attenuation, volumetric measurements). The company also distributes supporting software products including QTviewer and the QT Imaging-Olea Viewer, and operates the QTI Cloud Platform (InteleShare) as a subscription-based SaaS for image analytics, remote reading, and future AI/ML-enabled applications.
Product overview
QT Imaging offers a unified breast health imaging platform centered on its FDA 510(k)-cleared QTI Breast Acoustic CT Scanner — a radiation-free, compression-free 3D ultrasound tomographic system that generates quantitative volumetric images and biomarkers. The platform includes complementary software modules: QTviewer for image display and analysis, the QT Imaging-Olea Viewer for multimodality breast imaging integration, and the QTI Cloud Platform (InteleShare) for cloud-based analytics and AI-powered interpretation. The company recently achieved AMA Category III CPT code approval (X579T, effective January 2027) and has received regulatory clearances in the U.S., Saudi Arabia, UAE, and Israel for its scanner technology.
Differentiator
Problem solved
Functional benefit
Brands
- QTscan: Brand name for the Breast Acoustic CT Scanner imaging procedure
- QTI Breast Acoustic CT Scanner
- QT Imaging-Olea Viewer
- QTviewer
- InteleShare
- QT Imaging Olea Vision
Products and services
- QTI Breast Acoustic CT Scanner FDA 510(k)-cleared 3D ultrasound tomographic breast imaging system that generates true volumetric images without radiation, compression, or contrast agent injection. Uses low-frequency sound waves (300 kHz to 2.0 MHz) with five ultrasound transducer arrays for transmission and reflection imaging, producing quantitative biomarkers including speed of sound, attenuation, and volumetric measurements. Sold to healthcare facilities (breast imaging centers, radiology practices, IDNs) through exclusive distribution partners NXC Imaging (U.S.), Gulf Medical Co. (Saudi Arabia), and Al Naghi Medical Co. (UAE).
- QTviewer Software Standalone software application for storing and displaying QTscan images generated by the QTI Breast Acoustic CT Scanner. Enables radiologists to view 3D volume images in all orthogonal views (coronal, axial, sagittal) concurrently with customizable views, faster response time, and a research mode. Sold as an add-on to scanner purchasers.
- QT Imaging-Olea Viewer Unified multimodality breast imaging platform developed in collaboration with Olea Medical. Enables clinicians to view and correlate findings across multiple imaging sources (mammography, digital breast tomosynthesis, MRI, ultrasound) within a single configurable 3D/4D DICOM viewer. Incorporates advanced 3D rendering, quantitative assessment, subtraction tools, secure multi-institutional collaboration, and standardized clinical trial support.
- QTI Cloud Platform (InteleShare) Cloud-based SaaS platform for image analytics, remote reading, and population-scale screening, deployed via strategic collaboration with Intelerad Medical Systems (InteleShare). Enables research institutions and clinical sites to upload, store, anonymize, and share imaging data while maintaining data privacy compliance. Designed to deliver future AI/ML algorithms including automated lesion segmentation and computer-aided diagnosis to all connected QTI Breast Acoustic CT systems. Offered under subscription pricing with per-scan, per-facility, and per-feature tiers.
- Breast Retention Devices (single-use consumables) Single-use consumable accessories required for each QTscan imaging procedure, sold as recurring revenue tied to scanner utilization.
Quantifiable outcome
- Less than 1% variability in Speed of Sound measurements compared to 11-22% for breast MRI benchmarks
- +4 more outcomes
Companies that use QT Imaging
Customer profileNamed customers10 records
Segments5 records
Ideal customer profiles3 records
QT Imaging technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability4 records
Feature7 records
QT Imaging partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered minor, strategic and core.
- Rambam Health Care CampusminorIsrael's leading academic medical center. Clinical research collaboration to evaluate QT Imaging's Breast Acoustic CT technology in women with hereditary breast cancer risk. Israel recognized for leadership in breast cancer research, clinical innovation, and precision medicine with established national BRCA1/2 screening program.
- Olea MedicalstrategicCollaboration to integrate advanced visualization, quantitative analytics, and AI-ready imaging capabilities into QT Imaging's Cloud SaaS Platform. Partnership enables distribution of QT Imaging Olea Vision software, a customizable 3D/4D DICOM viewer integrating multiple imaging modalities including mammography, ultrasound, MR, and QT Imaging studies. Supports multimodality breast imaging workflows with subtraction tools, multi-institutional collaboration, and standardized clinical trial support.
- Al Naghi Medical Co.coreExclusive distribution partner for the United Arab Emirates territory. UAE Emirates Drug Establishment clearance received March 2026. Distribution agreement establishes $24 million revenue pipeline through 2028 with committed minimum of 43 scanners. Breast cancer accounts for 25% of all cancer cases in the UAE.
- Intelerad Medical SystemsstrategicStrategic collaboration to deploy InteleShare Research PACS and Cloud PACS across QT Imaging's clinical research and commercial networks. Partnership enables research institutions and clinical sites to upload, store, anonymize, and share imaging data while maintaining data privacy compliance. QT Imaging plans to leverage cloud infrastructure to deliver future AI/ML algorithms including automated lesion segmentation and computer-aided diagnosis to all connected QTI Breast Acoustic CT systems.
- NXC ImagingcoreExclusive U.S. distribution partner, a wholly owned subsidiary of Canon Medical Systems USA. NXC Imaging distributes QTI Breast Acoustic CT Scanners throughout the United States under a distribution agreement with committed minimum order quantities of 60 scanners. QT Imaging is transitioning to an integrated commercial model while continuing collaboration with NXC under existing distribution arrangement.
- Gulf Medical Co.coreExclusive distribution partner for Saudi Arabia. SFDA regulatory clearance received June 2026 enabling commercialization throughout the Kingdom. Breast cancer is the most commonly diagnosed cancer among women in Saudi Arabia, and the country is actively investing in healthcare modernization under Vision 2030.
- Canon Medical Systems CorporationcoreContract manufacturing partner for QTI Breast Acoustic CT Scanners. Canon Medical manufactures scanners in Japan alongside QTI's manufacturing in Novato, CA. NXC Imaging is a wholly owned subsidiary of Canon Medical Systems USA.
- University of Illinois Urbana-ChampaignstrategicResearch collaboration partner in $3.1 million NCI grant for breast cancer treatment monitoring. Collaboration involves Department of Electrical and Computer Engineering and Grainger College of Engineering. Five-year NIH research grant to develop imaging technology for assessing tumor response to neoadjuvant chemotherapy.
- Sunnybrook Health Sciences CentrestrategicResearch collaboration partner in $3.1 million NCI grant. Department of Radiation Oncology and Radiation Treatment Program at Sunnybrook, the largest cancer center in Canada. Five-year NIH/NCI research grant for developing imaging approach capable of accurate and early identification of response of breast cancer patients to neoadjuvant chemotherapy.
Scale indicators15 records
Recent moves10 records
Expansion highlights7 records
QT Imaging competitors and assessment
Company assessmentDirect peers
- Hologic: Hologic is the dominant player in breast imaging, with its Dimensions mammography and 3Dimensions digital breast tomosynthesis platforms, and is the most direct incumbent QT Imaging competes with for breast cancer screening budgets at US breast imaging centers and IDNs.
- Delphinus Medical Technologies: Delphinus offers SoftVue, a 3D whole breast ultrasound tomography system for dense breast supplemental screening, making it one of the closest direct competitors to QT Imaging's transmission ultrasound technology for the same dense-breast and supplemental-screening use case.
Broad incumbents
- GE HealthCare: GE HealthCare offers a broad breast imaging portfolio including Senographe mammography systems and ultrasound, and competes with QT Imaging for breast imaging equipment dollars at large hospital systems and IDNs globally.
- Philips: Philips offers mammography and ultrasound imaging systems and integrates them into enterprise imaging portfolios that compete head-to-head with QT Imaging's QTI Breast Acoustic CT Scanner in IDN and large radiology group purchasing.
- Siemens Healthineers: Siemens Healthineers manufactures MAMMOMAT mammography systems and broader imaging equipment, overlapping with QT Imaging in hospital and IDN breast imaging procurement decisions.
- Fujifilm: Fujifilm's digital mammography and women's health imaging systems compete with QT Imaging for breast imaging center and IDN capital equipment budgets, particularly in price-sensitive accounts.
Emerging players
- iCAD: iCAD provides AI-based breast cancer detection and risk-stratification software (ProFound AI) used with mammography, overlapping with QT Imaging's AI-powered lesion classification and biomarker analytics on the software layer.
- Densitas: Densitas provides AI-driven breast density and image quality analytics integrated with mammography programs, representing a software-layer peer to QT Imaging's quantitative biomarker and AI analytics strategy.
- Volpara Health: Volpara Health provides AI-based breast density assessment and risk analytics used alongside mammography, addressing the same dense-breast supplemental screening workflow QT Imaging targets with transmission ultrasound.
- Seno Medical Instruments: Seno Medical develops optoacoustic imaging for breast cancer diagnosis as an alternative to traditional biopsy, targeting the same breast imaging clinical decision points where QT Imaging's Breast Acoustic CT Scanner competes.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key highlights7 records
Customer concentration
QT Imaging social profiles
Digital presenceQT Imaging compliance and trust
Trust signalCompliance5 records
QT Imaging financial estimates
Financial estimateRevenue estimate
Valuation estimate
QT Imaging leadership team
Management profileNumber of profiles
Profiles12 records
QT Imaging subsidiaries and ownership
Company hierarchySubsidiaries1 record
QT Imaging funding detail
Funding detailFunding overview
Funding rounds6 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
QT Imaging M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about QT Imaging
What does QT Imaging do?
QT Imaging develops and sells the FDA 510(k)-cleared QTI Breast Acoustic CT Scanner, a 3D transmission ultrasound system that produces radiation-free, compression-free, contrast-free volumetric breast images and quantitative biomarkers (speed of sound, attenuation, volumetric measurements). The company also distributes supporting software products including QTviewer and the QT Imaging-Olea Viewer, and operates the QTI Cloud Platform (InteleShare) as a subscription-based SaaS for image analytics, remote reading, and future AI/ML-enabled applications.
Is QT Imaging a public or private company?
QT Imaging is a public company. It is classified as public and is currently operating.
When was QT Imaging founded?
QT Imaging was founded in 2011. It employs 11 to 50 people.
Where is QT Imaging based?
QT Imaging is headquartered in Novato, United States, in the North America region.
How does QT Imaging make money?
Three revenue lines are on record. Hardware Sales - Breast Acoustic CT Scanner is the primary driver. The others are cloud SaaS Platform Subscriptions and consumables - Breast Retention Devices.
Who are QT Imaging's main competitors?
Direct peers on record are Hologic and Delphinus Medical Technologies. Broad incumbents are GE HealthCare, Philips, Siemens Healthineers and Fujifilm. Emerging players are iCAD, Densitas, Volpara Health and Seno Medical Instruments.
Does QT Imaging have an API?
No public API is recorded for QT Imaging.
What industry is QT Imaging in?
QT Imaging's product category is Medical Imaging Equipment. Its primary akta.pro industry code is HLAHABAF, Mammography & Breast Imaging Systems, with a secondary code of HLACALAD, Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic). Its NAICS code is 334510 and its SIC code is 3841.